Axsome Therapeutics
Axsome Therapeutics develops and commercializes therapies for the management and treatment of pain and other neurological disorders.
| Company Details | |
|---|---|
| Title | Axsome Therapeutics |
| Industries | Biopharma, Biotechnology, Therapeutics |
| Headquarters Regions | Greater New York Area, East Coast, Northeastern US |
| Headquarters Location | New York, New York, United States |
| No Of Employees | 101-250 |
| Operating Status | Active |
Description
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where current treatment options are limited or inadequate. Axsome has a balanced portfolio of clinical development stage as well as research stage products. Axsome Therapeutics aims to become a fully integrated biopharmaceutical company that develops and commercializes differentiated products which increase the armamentarium of caregivers and improve the lives of patients. While the focus of the company is on developing its internally derived product candidates, Axsome also evaluates potential in-licensing opportunities to supplement its current portfolio.